Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be graded.

• Samaratunga H Aquesta Uropathology and University of Queensland, Brisbane, Qld, Australia.
• Delahunt B Department of Pathology and Molecular Medicine, Wellington School of Medicine and Health Sciences, University of Otago, Wellington, New Zealand. Electronic address: brett.delahunt@otago.ac.nz.
• Egevad L Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
• Srigley JR Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
• Billis A Department of Anatomic Pathology, School of Medical Sciences, State University of Campinas (Unicamp) Campinas, SP, Brazil.
• Bostwick DG Bostwick Laboratories, Orlando, FL, USA.
• Camparo P Department of Pathology, Centre de Pathologie Amiens, Amiens, France.
• Cheng L Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
• Clouston D TissuPath, Mount Waverley, Vic, Australia.
• Denham J School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia.
• Furusato B Department of Pathology, Nagasaki University Graduate School of Biomedical Sciences and Cancer Genomics Unit, Clinical Genomics Center, Nagasaki University Hospital, Sakamoto, Nagasaki, Japan.
• Hartmann A Institute of Pathology, University Erlangen-Nürnberg, Erlangen, Germany.
• Jufe L Servicio de Anatomía Patológica. Hospital General de Agudos J.M. Ramos Mejía, Ciudad Autónoma de Buenos Aires, Argentina.
• Kench J Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and Central Clinical School, University of Sydney, Sydney, NSW, Australia.
• Kenwright DN Department of Pathology and Molecular Medicine, Wellington School of Medicine and Health Sciences, University of Otago, Wellington, New Zealand.
• Kristiansen G Institue of Pathology, Reference Centre for Uropathology, University Hospital Bonn, Bonn, Germany.
• Leite KRM Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil.
• MacLennan GT Department of Pathology and Urology, Case Western Reserve University, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
• Merrimen J Division of Anatomical Pathology, QEII Health Sciences Centre, Halifax, NS, Canada.
• Moch H University and University Hospital Zurich, Department of Pathology and Molecular Pathology, Zurich, Switzerland.
• Oxley J North Bristol NHS Trust, Bristol, UK.
• Pan CC Department of Pathology, Taipei Veterans General Hospital, Taipei, Taiwan.
• Paner G Departments of Pathology and Surgery (Section of Urology) University of Chicago, Chicago, IL, USA.
• Ro J Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Weill Medical College of Cornell University, Houston, TX, USA.
• Sesterhenn IAM Joint Pathology Center, Silver Spring, MD, USA.
• Shanks J Department of Histopathology, The Christie NHS Foundation Trust, Manchester, UK.
• Thunders M Department of Pathology and Molecular Medicine, Wellington School of Medicine and Health Sciences, University of Otago, Wellington, New Zealand.
• Tsuzuki T Department of Surgical Pathology, Aichi Medical University, School of Medicine, Nagakute, Japan.
• Wheeler T Department of Pathology and Laboratory Medicine, Baylor St. Luke's Medical Center and Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA.
• Yaxley JW Department of Medicine, University of Queensland, Wesley Urology Clinic, Royal Brisbane and Women's Hospital, Brisbane, Australia.
• Varma M Department of Cellular Pathology, University Hospital of Wales, Cardiff, UK.

Show more…

ISUP grade

Prostate adenocarcinoma

intraductal carcinoma of prostate

prognosis

Carcinoma, Ductal

Humans

Male

Neoplasm Grading

Prostatic Neoplasms